Growing demand from detergents, pharmaceuticals, and food & beverages Sector will boost market at considerable pace during projected period

The global Enzymes Market is expected to reach USD 17.50 billion by 2024, according to a new report by Grand View Research, Inc. Growing demand for enzymes in food & beverage products as they improve quality and eliminate deficiencies in the products is expected to propel industry growth in the near future.

Increasing demand for bioethanol and biodiesel in emerging economies including India, Brazil, and Thailand will augment industry growth over the forecast period. Growing number of government investments along with R&D activities in industrial enzymes will drive demand over the next eight years.

Rising population along with rising living standard will drive processed foods demand, which in turn will stimulate industry expansion. In addition, emerging protein design algorithms, along with growing inexpensive DNA sequencing technology will open new market avenues over the next seven years.

Carbohydrases accounted for 47.7% of the global market share in 2015, dominating the enzymes industry and the segment is expected to show significant growth in light of high usage in animal feed, textile, food & beverages, and pharmaceutical applications. Moreover, mounting usage of artificial sweeteners, prebiotic products, and juices is expected to fuel product demand over the forecast period.

Request for Sample Copy of this report: http://www.grandviewresearch.com/industry-analysis/enzymes-industry

Further key findings from the report suggest

  • Specialty enzymes are anticipated to witness the fastest growth at a CAGR of 9.2% from 2016 to 2024 on account of increasing awareness regarding therapies for chronic diseases, along with growing incidences of digestive enzyme disorders. Moreover, increasing usage of the ingredient for diagnostic solutions is expected to augment growth. Chemical reactions in research & biotechnology are accelerated by making the use of enzymes. They also optimize the yield of the production processes, which is expected to bolster demand over the forecast period.
  • Animal feed is likely to witness significant growth at a CAGR of 9.0% from 2016 to 2024 as a result of mounting demand for swine, bovine, poultry and aquaculture species. Growing global meat production coupled with rising health concern regarding meat quality will augment animal feed demand, which is expected to stimulate industry expansion.
  • North America enzymes market was valued at USD 3.59 billion in 2015 and will show high gains in light of favorable government policies along with a robust manufacturing base in the U.S. Growing demand for animal feed and biofuels in the U.S. is expected to drive market size.
  • Latin America accounted for 8.3% of the overall enzymes market and will show substantial growth in light of rapid industrialization coupled with increasing biodiesel production in Brazil and Argentina.
  • Key industry players include Novozymes, Danisco, Royal DSM, BASF SE, DuPont, Lonza Group, and Advanced Enzymes Technologies Ltd. In January 2014, DuPont launched LAMINEX MaxFlow 4G enzyme, intended for increasing texture, taste and appearance of beer in beverages applications.

View All Reports of Same Category by Grand View Research: http://www.grandviewresearch.com/industry/catalysts-and-enzymes

Grand View Research has segmented the global enzymes market on the basis of type, product, application and region:

Global Enzymes Type Outlook (Revenue, USD Million, 2013 – 2024)

  • Industrial enzymes
  • Specialty enzymes

Global Enzymes Product Outlook (USD Million, 2013 – 2024)

  • Carbohydrase
  • Proteases
  • Lipases
  • Polymerases & nucleases
  • Others

Global Industrial Enzymes Application Outlook (Revenue, USD Million; 2012 – 2022)

  • Food & Beverages
  • Detergents
  • Animal Feed
  • Textile
  • Paper & Pulp
  • Nutraceutical
  • Personal Care & Cosmetics
  • Wastewater

Global Specialty Enzymes Application Outlook (Revenue, USD Million; 2012 – 2022)

  • Pharmaceuticals
  • Research & biotechnology
  • Diagnostics
  • Biocatalyst

Global Enzymes Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
  • U.S.
  • Mexico
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • MEA

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-enzymes-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Asia Pacific Empty Capsules Market is likely to grow with the highest CAGR of 7.9% over the forecast period

The global Empty Capsules Market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.

The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.

The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.

The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.

In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.

However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.

Request for Sample Copy of this report: http://www.grandviewresearch.com/industry-analysis/empty-capsules-market

Further key findings from the study suggest:

  • In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
  • Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
  • In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
  • The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
  • The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
  • Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.

Browse All Reports of Same Category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region:

Global empty capsules market, by product (USD Million, 2013 – 2024)

  • Gelatin Capsules
  • Non-Gelatin capsules

Global empty capsules market by therapeutic application (USD Million, 2013 – 2024)

  • Antibiotic and antibacterial drugs
  • Vitamin and dietary supplements
  • Antacids and antiflatulent preparations,
  • Antianemic preparations,
  • Anti-inflammatory and anti-rheumatic drugs,
  • Cardiac therapy drugs,
  • Cough and cold preparations

Global empty capsules market by end-user (USD Million, 2013 – 2024)

  • Pharmaceutical industries
  • Nutraceutical industries
  • Cosmeceutical industries
  • Research laboratories

Empty capsules market, by region (USD Million, 2013 – 2024)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • Asia Pacific
  • Japan
  • China
  • Latin America
  • Brazil
  • Mexico
  • MEA
  • South Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-empty-capsules-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Rising number of ongoing Clinical Trials is playing major role in Market growth Till 2024

eClinical solutions market is expected to reach USD 10.5 billion by 2024, according to a new report published by Grand View Research Inc. The eClinical solutions market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors attributing towards the growth of the market are increase in the research and development activities by numerous biopharma and pharma companies, increasing application of software solutions in clinical trials, upsurge in the government funding to promote clinical research programs, rise in the number of Contract Research Organizations (CROs) and life sciences organizations, and increasing customer base.

Additionally, factors such as increasing outsourcing of clinical trials to CROs, escalating clinical research programs in Asian countries, as well as, the development of cost-effective modules are expected to be opportunistic for the industry growth. However, the shortage of skilled labor force, high implementation costs of the eClinical solutions and the lack of awareness of clinical data sciences software in the research community are likely to hinder the growth of the market in the near future.
eclinical-solutions-market.png
The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, end-user, and region. Based on the product, the industry is categorized into clinical analytics platforms, electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), clinical data integration platforms, safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF).

The other segments of the market include delivery mode (web-hosted, licensed enterprise, and cloud-based), clinical trial phases (phase I, phase II, phase III, and phase IV), and end-user application (consulting service companies, medical device manufacturers, hospitals, contract research organizations, pharmaceutical, and biopharmaceutical companies). On the basis of regions, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa).

Request For Sample Copy of this report: http://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market

Further key findings from the study suggest:

  • In 2016, North America is estimated to lead the market with the largest share in the eClinical solutions industry. The rising number of ongoing clinical trials, high demand for technologically advanced products, and increasing financial support from the government is anticipated to boost the industry growth.
  • The eCOA segment is anticipated to witness the highest growth rate during the forecast period, whereas the EDC and CDMS segment is estimated to lead the market in the year 2016. Factors attributing to the growth of the industry are the increasing application of mobile and digital technologies, as well as, an upsurge in the demand for eDiaries in clinical trials for the collection of patient’s self-reports by pharmaceutical companies.
  • The eClinical solutions industry comprises several local as well as global players. Some of the major players in this industry include Oracle Corporation, Medidata Solutions Inc., Parexel International, Inc., and Datatrak, among others.

Browse All Reports of Same Category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global eClinical solutions market on the basis of end-user application and region:

eClinical Solutions Product Outlook (Revenue, USD Million, 2013 – 2024)

  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS)
  • Clinical Analytics Platforms
  • Randomization and Trial Supply Management (RTSM)
  • Clinical Data Integration Platforms
  • Electronic Clinical Outcome Assessment (eCOA)
  • Safety Solutions
  • Electronic Trial Master File (eTMF)

eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2013 – 2024)

  • Web-hosted (On-demand)
  • Licensed Enterprise (On-premise)
  • Cloud-based

eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2013 – 2024)

  • Consulting Service Companies
  • Medical Device Manufactures
  • Hospitals
  • CROs
  • Pharmaceutical Biopharmaceutical Companies

eClinical Solutions Clinical Trial Outlook (Revenue, USD Million, 2013 – 2024)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

eClinical Solutions Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-eclinical-solutions-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Latest Emerging Trends in Medical Device Industry is anticipated to driving market development over the estimated period

Global disposable medical sensors market is expected to reach USD 7,543.1 million by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of HAIs (hospital acquired infections) and government initiatives aimed at reducing central-line associated bloodstream infections and surgical site infections in ward located and ICU patients are expected to serve the market as high impact rendering drivers. Introduction and subsequent rise in usage rates of novel technologies such as cancer tracking sensors, Hba1c sensors and MEMS pressure sensors is expected to boost future market growth.
disposable-medical-sensors-industry.png
Strip sensors dominated the overall product segment in terms of revenue and were valued at USD 1,800.2 million in 2013. Increasing prevalence of chronic diseases such as diabetes, cancer and cardiovascular disorders and the consequent rise in demand for diabetes and cancer biomarkers strip sensors are some factors accounting for its large share.

To Request a Sample Copy of Report: http://www.grandviewresearch.com/industry-analysis/disposable-medical-sensors-industry

Further key findings from the study suggest:

  • Image sensors are expected to be a high growth segment over the forecast period owing to the introduction of technology advancements such as optic fiber technology; low power miniature CMOS image sensors and ZSRL image sensors. These sensors enable medical imaging and endoscopy systems to function with accuracy and therefore, help in effective diagnostic and therapeutic interventions.
  • Disposable medical sensors based diagnostic applications dominated the overall market with revenue estimated at over 1,700.0 million in 2013. Increasing demand for point of care diagnoses such as i-stats, biosensors for the diagnosis and monitoring of glucose levels in emergency rooms is expected to drive the market during the forecast period.
  • North America dominated the global market, accounting for over 35% of total revenue in 2013 on account of the presence of sophisticated healthcare infrastructure and growing R&D spending for the development of miniaturized and convenient medical sensors.
  • Asia Pacific disposable medical sensors market is expected to grow at a CAGR of over 11.0% over the next six years, which is the highest among all regions. Increasing demand for home healthcare biosensors and improving healthcare infrastructure in emerging countries such as China and India are some factors contributing to its rapid growth.
  • Some key players of disposable medical sensors include Honeywell International, Inc, Covidien Plc, STMicroelectronics, Given Imaging, Inc., GE Healthcare, Medtronic, Freescale Semiconductor, Inc., Philips Healthcare, Analog Devices, Smiths Medical, Measurement Specialties and Sensirion AG.

View All Reports of Same Category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

For the purpose of this study, Grand View Research has segmented the disposable medical sensors market on the basis of product, technology, application and region:

Global Disposable Medical Sensors Product Outlook (Revenue, USD Million, 2012 – 2020)

  • Wearable sensors
  • Implantable sensors
  • Invasive sensors
  • Ingestible sensors
  • Strip sensors

Global Disposable Medical Sensors Technology Outlook (Revenue, USD Million, 2012 – 2020)

  • Temperature sensors
  • Pressure sensors
  • Image sensors
  • Biosensors
  • Accelerometers
  • Others

Global Disposable Medical Sensors Application Outlook (Revenue, USD Million, 2012 – 2020)

  • Diagnostic
  • Patient monitoring
  • Therapeutic

Disposable Medical Sensors Regional Outlook (Revenue, USD Million, 2012 – 2020)

  • North America
  • Europe
  • Asia Pacific
  • ROW

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-disposable-medical-sensors-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

U.S. is the major R&D hub for the medical sector and expected to increase the demand for Bioresorbable Polymer

The global Bioresorbable Polymer Market is anticipated to reach USD 2.26 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand in the medical sector, owing to its hydrolytically degrading property in the body is projected to increase the global market growth.
global-bioresorbable-polymers-market
The increasing health awareness, improving healthcare facilities worldwide and growing surgery procedures across the globe will have a positive impact on the bioresorbable polymers industry growth in the overcoming years.

The increasing product demand for drug delivery application is another key factor for market development over the forecast period. The harmless decomposition and its chemically neutral nature in the body make them suitable for drug delivery segment.

The PLA-based product demand exceeded 89 tons in 2015, which is projected to remain as the largest and fastest growing segment over the upcoming years. The PLA market is growing dramatically in the pharmaceutical sector owing to its distinctive feature of being biodegradable and biocompatible.

Request for Sample Copy of this report: http://www.grandviewresearch.com/industry-analysis/bioresorbable-polymers-market

Further Key Findings from the Study Suggest:

  • The global bioresorbable polymers demand was over 298 tons in 2015 and is expected to grow at an estimated CAGR of 14.3% over the projected period
  • The PCL-based product market accounted for over 13% of the total revenue in 2015
  • Orthopedics was the leading application segment with demand exceeding 45% in 2015
  • The bioresorbable polymer market in drug delivery application is estimated to have the highest growth at a CAGR of over 14% from 2016 to 2025
  • The U.S. polyglycolic acid product market generated revenue worth of USD 31.5 million in 2015 and is expected to reach a total revenue of over USD 110 million by 2025
  • Polysaccharides demand in Europe is estimated to exceed a total revenue of USD 470 million by the end of forecast period
  • Factors such as changing consumption patterns, technological advancements, and rising government initiatives, are anticipated to influence the market in the overcoming years
  • Influential companies operating in this market include Carbion NV, Evonik Industries AG, Poly-Med, Inc., Foster Corporation and KLS Martin Group
  • Evonik and Carbion dominated the global market together accounting for over 50% of the total revenue in 2015

Browse All Reports of Same Category by Grand View Research: http://www.grandviewresearch.com/industry/specialty-bio-based-and-water-soluble-polymers

Grand View Research has segmented the bioresorbable polymer market on the basis of product, application and region:

Bioresorbable Polymers Product Outlook (Volume, Tons; Revenue, USD Million, 2014 – 2025)

  • Polysaccharides
  • Proteins
  • Polylactic acid
  • Polyglycolic acid
  • Polycaprolactone
  • Others

Bioresorbable Polymers Application Outlook (Volume, Tons; Revenue, USD Million, 2014 – 2025)

  • Drug Delivery
  • Orthopedics
  • Others

Bioresorbable Polymers Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 – 2025)

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Asia Pacific
  • China
  • India
  • Japan
  • Middle East and Africa
  • Central & South America

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-bioresorbable-polymers-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Flavonoid as an anti-cancer drug is anticipated to driving factor of market till 2025

The global Flavonoids Market is expected to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Changing consumer lifestyles and rising demand for beauty & health supplements are expected to propel flavonoids consumption over the forecast period.
us-flavonoids-market.png
Developed countries such as Denmark, France, Australia, Belgium, Norway, and the U.S. are characterized by high cancer prevalence. Application of flavonoid as an anti-cancer drug is expected to be the major factor driving growth in these countries, over the forecast period.

Rising demand for convenience food products has increased utilization of flavonoids in functional food. Moreover, smoothing and antioxidant properties allow it to be used in the cosmetics industry for skin care applications. These are also being used to develop drugs for the treatment of various other diseases including diabetes and cardiovascular problems, prevailing worldwide, further increasing demand.

Request For Sample Copy of this report: http://www.grandviewresearch.com/industry-analysis/flavonoids-market

Further key findings from the report suggest:

  • Anthocyanins were the most commonly consumed flavonoids in 2015 with a market share of over 40% in 2015. Growing demand from the nutraceuticals and functional food segment is expected to drive this market over the forecast period.
  • The functional beverages segment is expected to grow at a CAGR of over 12% from 2016 to 2025, in terms of revenue. Antioxidant properties of this product are now being introduced in non-alcoholic beverages including soft drinks, nutraceutical drinks, and energy drinks, propelling demand in this application.
  • The flavonoids market in functional foods was valued over USD 130 million in 2015 on account of anti-diabetic and anti-carcinogenic properties which are expected to increase their consumption in nutraceutical and functional food products.
  • North America demand is expected to rise on account of rapid economic development with the U.S. and Canada being major nutraceutical markets in this region, triggering growth over the forecast period.
  • The market in Central & South America is projected to grow at the second highest CAGR of over 9% from 2016 to 2025, driven by growing demand from emerging economies such as Brazil and Argentina.
  • In January 2016, Cayman Chemical Company, one of the leading manufacturers of this product, acquired Biomol GmbH, a Germany-based distributor of research reagent chemicals. This acquisition helped the company strengthen its position in Europe.

Browse All Reports of Same Category by Grand View Research: http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the global flavonoids market on the basis of product, application and region:

Global Flavonoids Product Outlook (Volume, Tons: Revenue, USD Million, 2014 – 2025)

  • Anthocyanins
  • Flavones
  • Anthoxanthins
  • Others

Global Flavonoids Application Outlook (Volume, Tons: Revenue, USD Million, 2014 – 2025)

  • Functional beverages
  • Functional food
  • Dietary supplements
  • Others

Global Flavonoids Regional Outlook (Volume, Tons: Revenue, USD Million, 2014 – 2025)

  • North America
  • U.S.
  • Europe
  • Germany
  • Asia Pacific
  • China
  • Latin America
  • Brazil
  • Middle East & Africa

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-flavonoids-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Fertilizer Additives Market: Ammonium nitrate is projected to grow at the highest CAGR of 4.7% from 2016 to 2024

The global fertilizer additives market is projected to reach USD 3.94 billion by 2024, according to a new report by Grand View Research, Inc. Growing fertilizer industry and shrinking arable land are projected to drive the market over the forecast period.

Additives are added to fertilizers in order to inhibit the loss of key nutrients such as nitrogen phosphorus, potassium, and sulfur, among others. The additives, which are available in both, solid and liquid forms, are used during storage and transportation of fertilizers.

Anti-caking was the most popular function of additives in 2015. Caking of fertilizers is one of the major problems faced by farmers, retailers and manufacturers, particularly during rains. Change in storage temperatures also results in caking. Additives are used to overcome these challenges.

To request a sample copy of this report: http://www.grandviewresearch.com/industry-analysis/fertilizer-additives-market

Further key findings from the report suggest

  • Urea dominated the end product segment in 2015 with a share of 55.6%. it is widely used globally, since it contains the highest amount of nitrogen among all fertilizers. Factors such as shrinking arable land have increased the importance of products such as urea and ammonium nitrate, which help in cultivation in a short span of time, in limited available land.
  • Anti-caking dominated the function segment in 2015. This segment is projected to grow at the highest CAGR of 3.7 over the forecast period. Additives are used to avoid the formation of lumps in fertilizers, enabling safe storage and transportation.
  • Asia Pacific led the global market with a share of 58.8% in 2015. This region is home to some of the emerging countries such as China and India. The market in India, where, agriculture is the primary occupation, is projected to drive the market from 2016 to 2024.
  • The weather in this part of the world gets hot and humid during summer, which can lead to caking and loss of essential nutrients in fertilizers. Thus, additives are expected to play an important role in maintaining the quality of fertilizers in this region.
  • Clariant, KAO Corporation, Novochem Group, and ChemSol, LLC are some of the key manufacturers of additives. Other players include Filtra Catalysts & Chemicals Ltd., Solvay, Arrmaz, Chemipol, Forbon Technology, Michelman, Tolsa Group, and Amit Trading Ltd.
  • The companies adopted various development strategies such as new product developments, expansions, mergers & acquisitions, and agreements, partnerships, & joint ventures to establish themselves as market leaders and expand their global reach.

Browse All Reports of Same Category by Grand View Research: http://www.grandviewresearch.com/industry/agrochemicals-and-fertilizers

Grand View Research has segmented the global fertilizer additives market on the basis of application and region:

Fertilizer Additives Function Outlook (Revenue, USD Million, 2013 – 2024)

  • Corrosion Inhibitors
  • Hydrophobic Agents
  • Anti-dusting Agents
  • Anti-caking Agents
  • Others (Anti-foaming Agents and Coating Agents)

Fertilizer Additives End Product Outlook (Revenue, USD Million, 2013 – 2024)

  • Urea
  • Ammonium Nitrate
  • Ammonium Phosphate
  • Ammonium Sulfate
  • Others (Monoammonium Phosphate, Triple Super Phosphate)

Fertilizer Additives Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
  • U.S.
  • Europe
  • Germany
  • France
  • Asia Pacific
  • China
  • India
  • Latin America
  • Brazil
  • Middle East & Africa (MEA)

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-fertilizer-additives-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com